The Bundeskartellamt has initiated an administrative proceeding against Deutsche Bahn AG. The proceeding concerns the sale of tickets of Deutsche Bahn AG via so-called mobility platforms.
Andreas Mundt, President of the Bundeskartellamt said, “Innovative, modern mobility concepts and the online sale of travel tickets naturally also rely on rail travel. Digital platforms via which travellers can book all means of transport to their destination from a single source will therefore be an important market in the future. These providers rely on Deutsche Bahn AG for information. According to the information currently available, mobility platforms do not, for example, receive real-time information about departures and delays. Deutsche Bahn AG is also said to set out extensive requirements for online marketing and granting rebates. We are following up these allegations and will examine whether Deutsche Bahn AG is unlawfully restricting the visibility and attractiveness of mobility platforms for consumers.”
Travellers can search travel information on mobility platforms either online or via apps, compare means of transport and book tickets. Some mobility platforms even offer to organise and book a complete voyage with different means of transport.
One question in the focus of the Bundeskartellamt’s investigation is whether Deutsche Bahn AG imposes restrictions on mobility platforms in respect of advertising in app stores, search engines and social networks.
Full Content: Market Screener
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas